Cardlytics Reports Q4 and FY 2023 Financial Performance

March 14, 2024

DENVER, Colo., Mar 14, 2024 (247marketnews.com)- Cardlytics, Inc. (NASDAQ:CDLX) reported its fourth quarter and full year 2023 financial results.

Total fourth quarter revenue increased 8.1%, to $89.2 million, compared to $82.5 million in 2022, while total 2023 revenue was $309.2 million, an increase of 3.6% over 2022’s $298.5 million.

2023 annual billings reached $453.4 million, an increase of 2.5% over 2022’s $442.5 million.

Adjusted 2023 EBITDA was $3.8 million, an increase of $48.9 million compared to 2022’s $45.2 million loss, while 2023 adjusted net loss was $(11.4) million, or $(0.31) per diluted share, based on 36.5 million weighted-average common shares outstanding in 2023, compared to a Adjusted Net Loss of $(60.3) million, or $(1.80) per diluted share, based on 33.4 million weighted-average common shares outstanding in 2022.

However, adjusted fourth quarter 2023 net income was $5.7 million, or $0.14 per diluted share, based on 39.5 million weighted-average common shares outstanding, compared to its adjusted net $9.7 million loss, or $(0.29) per diluted share, based on 33.4 million weighted-average common shares outstanding in the fourth quarter of 2022.

“The fourth quarter capped a transformational year for Cardlytics,” said Karim Temsamani, CEO of Cardlytics. “With our cost structure rebalanced, we can now focus on building a best-in-class platform with top-tier targeting and a differentiated user experience that will help deliver the best outcomes for our partners, their customers and our advertisers.”

“Achieving growth and improving our capital structure are our top priorities,” said Alexis DeSieno, CFO of Cardlytics. “In 2023, we turned to full year positive Adjusted EBITDA for the first time since 2019, and our Q1 guidance implies further acceleration. We are on a path to double-digit billings growth in 2024 and positive operating cash flow on an annual basis.”

It’s trading at $11.15 +2.96 (+36.22%), on 1.1M shares.

Its 52-week range is $2.57 to $19.57 and its afterhours high is $11.9976.

It has a very interesting gap from November and only a little resistance to the $14 level.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (CDLX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.